Pravastatin and Paroxetine Exposure Explored for Links to Type II Diabetes Mellitus

Type 2 Diabetes Mellitus (T2DM) is a chronic condition characterized by impaired glucose regulation, leading to hyperglycemia and severe complications like cardiovascular disease (CVD), chronic renal failure, and diabetic retinopathy. CVD, the leading cause of death globally, often stems from cholesterol buildup in arteries, forming plaques that cause blockages. Statins, such as Pravastatin, are crucial in reducing cholesterol and mitigating CVD risk. Additionally, depression is a prevalent mental disorder. Understanding how common medications like Pravastatin and Paroxetine might influence T2DM risk is vital, given the widespread use of these drugs and the significant health burden of T2DM.